60 Degrees Pharmaceuticals, Inc. Financial Overview
60 Degrees Pharmaceuticals, Inc.'s market cap is currently $5.17M. The company's EPS TTM is $-0.665; its P/E ratio is -0.11; 60 Degrees Pharmaceuticals, Inc. is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-0.57. See an overview of income statement, balance sheet, and cash flow financials.
